Context: Bisphenol A (BPA) is one of the world's highest-volume chemicals in use today. Previous studies have suggested BPA disturbs body weight regulation and promotes obesity and insulin resistance. But epidemiological data in humans were limited.
B
isphenol A (BPA), an environmental estrogen, is one of the world's highest-volume chemicals in use today (1) (2) (3) . Studies in vivo have shed light on the mechanisms by which BPA disturbs body weight regulation and promotes obesity, including effects of BPA on adipocyte differentiation, lipid accumulation, insulin resistance, glucose transport, and adiponectin secretion (4 -7) . Data from the U.S. National Health and Nutrition Survey (NHANES) 2003-2004 and 2005-2006 reported a positive association between BPA and obesity (8) . Recent human data showed a positive relationship between BPA and insulin resistance in women with polycystic ovary syndrome (9) . However, epidemiological study was limited, and whether BPA associates with obesity and insulin resistance was still needed to be confirmed.
In the present study, we aim to investigate whether higher BPA exposure associates with obesity and insulin resistance in Chinese adults aged 40 yr or older.
Subjects and Methods

Study design and participants
Subjects were recruited from Songnan Community, Baoshan District, Shanghai, China, as reported previously (10) . In June and July 2008, 10,185 registered permanent residents aged 40 yr or older received a screening examination, and in June and August 2009, 3455 participants from the 10,185 residents were randomly selected and received a comprehensive survey. Among 3455 study participants with blood and urine samples included in this survey, 65 subjects were excluded due to failed collection of clinical examination results or of self-reported liver diseases, including hepatitis, cirrhosis, or malignancy. Thus, a total of 3390 participants were finally included in the analysis. The participants (3390 subjects) and the nonparticipants (6795 subjects) were similar in characteristics such as sex and age. All procedures used in this study were in accordance with institutional guidelines. The Committee on Human Research at Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, approved the study protocol, and all study participants provided written informed consent.
Data collection
Sociodemographics, medical history, and lifestyle factors were documented. Weight, height, waist circumference, and blood pressure were measured by experienced nurses. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Three sitting blood pressure measurements taken consecutively at 5-min intervals using an automated electronic device (OMRON model HEM-752 FUZZY; Omron Co., Dalian, China) were averaged for analysis. All the participants were subjected to a 75-g oral glucose tolerance test (OGTT), and blood samples were collected at 0 and 2 h during the OGTT. Plasma glucose was measured using the glucose oxidase method on an autoanalyzer (ADVIA-1650 Chemistry System; Bayer Corp., Leverkusen, Germany), and serum insulin concentration was measured by an electrochemiluminescence assay (Roche Diagnostics, Basel, Switzerland). Measurements of urinary creatinine, serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), alanine aminotransferase (ALT), ␥-glutamyltransferase (GGT), and high-sensitivity C-reactive protein (hs-CRP) were performed with an autoanalyzer (ADVIA-1650 Chemistry System).
Total (free and conjugated) urinary BPA concentration was measured in a spot morning urine sample by a sensitive and selective liquid chromatography-tandem mass spectrometry at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, as reported previously (10) . For BPA concentrations less than 0.30 ng/ml, the lower limit of quantification, a value of 0.15 ng/ml was assigned for the purpose of analysis (11) .
Generalized overweight was defined as having a BMI of 24 to less than 28 kg/m 2 , and obesity was defined as having a BMI of28 kg/m 2 or higher according to Chinese criteria (12) . Abdominal obesity was defined using the Chinese criteria as waist circumference at least 90 cm for men and at least 85 cm for women (13) . Insulin resistance was defined as homeostasis model assessment of insulin resistance (HOMA-IR) higher than 2.50.
Statistical analysis
Statistical analysis was performed with SAS version 8.1 (SAS Institute, Cary, NC), and a P value Ͻ0.05 (two sided) indicated statistical significance. Data were summarized as means and SD for continuous variables or numbers and percentages for categorical parameters. The concentrations of urinary BPA, serum TG, fasting insulin, hs-CRP, ALT, and GGT were logarithmically transformed to achieve a normal distribution. Linear regression analysis was used to test for trend of the changes of variables across the quartiles of urinary BPA concentrations, and logistic regression models were employed to evaluate the odds ratios (OR) and 95% confidence intervals (CI) of having generalized overweight and obesity, abdominal obesity, and insulin resistance for higher quartiles of BPA compared with the lowest quartile.
Results
Compared with the participants in the lowest quartile, those in the highest quartile of urinary BPA were younger and more likely to be men and had significantly higher BMI, waist circumference, fasting plasma glucose, fasting serum insulin, and GGT and lower HDL-C and urinary creatinine concentration (all P for trend Ͻ0.05) ( Table 1) . Table 2 shows that increased BPA was associated with an increased prevalence of generalized and abdominal obesity. Compared with the first quartile, the OR (95% CI) for generalized obesity were 1.14 (0.87-1.50) for the second, 1.19 (0.90 -1.57) for the third, and 1.50 (1.15-1.97) for the fourth quartile of urinary BPA concentration, after adjusting for age, sex, urinary creatinine, smoking, alcohol drinking, education levels, systolic blood pressure, HDL-C, LDL-C, TC, TG, hs-CRP, fasting plasma glucose, fasting serum insulin, ALT, and GGT. There was no significant association between increased urinary BPA and generalized overweight in the similar fully adjusted logistic regression model. Relative to the first quartile, the OR (95% CI) for abdominal obesity were 1.26 (1.02-1.57) for the second, 1.28 (1.03-1.59) for the third, and 1.28 (1.03-1.60) for the fourth quartile in the fully adjusted model.
For insulin resistance, the fourth quartile of urinary BPA had the highest OR (1.56; 95% CI ϭ 1.26 -1.94) in the age-, sex-, and urinary creatinine-adjusted model. After further adjusting for BMI, waist circumference, smoking, alcohol drinking, education levels, systolic blood pressure, HDL-C, LDL-C, TC, TG, hs-CRP, ALT, and GGT, the fourth quartile increased the prevalence of insulin resistance by 37% (OR ϭ 1.37; 95% CI ϭ 1.06 -1.77), compared with the first quartile. In the participants with BMI under 24 kg/m 2 (n ϭ 1401), the OR (95% CI)
for insulin resistance were 1.55 (0.97-2.46) for the second, 1.04 (0.64 -1.70) for the third, and 1.94 (1.20 -3.14) for the fourth quartile after full adjustment. In the participants with BMI of 24 kg/m 2 or higher (n ϭ 1989), the age-, sex-, and urinary creatinine-adjusted OR (95% CI) for insulin resistance were 1.03 (0.79 -1.35), 1.09 (0.84 to1.43), and 1.26 (0.97 to1.65) for quartile 2, 3, and 4, respectively. After further adjustment, still no significant association was observed ( Table 2 ).
Discussion
In this study among 3390 Chinese adults aged 40 yr and older, we reported a positive and significant association between urinary BPA concentration and the prevalence of generalized obesity, abdominal obesity, and insulin resistance. Obesity is a multifactorial disease influenced by a complex interaction between genetic, behavioral, and environmental factors (14, 15) . Several potential mechanisms could account for the actions of BPA in the development of obesity. First, in vitro studies of 3T3-L1 cells have revealed that micromolar concentration of BPA could enhance adipocyte differentiation and lipid accumulation in target cells, and BPA was found to increase gene expression of adipogenic transcription factors in 3T3-L1 preadipocytes (16) . If similar effects of BPA occur in vivo, they would be expected to play an important role in increasing adiposity and body weight. Second, results of in vitro studies have indicated similarities between the action of estradiol and BPA on the inhibition of adiponectin secretion from human adipocyte in a dose-dependent manner (16) . And BPA has been found to increase insulin, mimicking estradiol, and influence the insulin-secreting ␤-cells and glucagon-secreting ␣-cells of the pancreas, leading to hy- perinsulinemia and finally to insulin resistance, a factor contributing to the development of obesity (4, 5) . Third, numerous studies have shed light on the effect of BPA on the developing of the brain, which is a sensitive target organ for BPA (17) . Early exposure to BPA could disturb the development and maturation of brain circuits, which contribute to the regulation of food intake and metabolism, which start during the perinatal period, and then affect energy homeostasis (18) . (8) . They found that the OR for generalized and abdominal obesity were more prominent in quartile 2 of BPA than in other quartiles, whereas we found a gradual increasing of the OR according to the increment of BPA quartiles for generalized obesity and the highest OR of the fourth BPA quartile for abdominal obesity. Kandaraki et al. (9) found that BPA was positively associated with Matsuda index in women with polycystic ovary syndrome (r ϭ 0.273; P Ͻ 0.05), indicating a possible impact of BPA on insulin action. We found a positive association between BPA and insulin resistance that was evaluated by HOMA-IR, and the effect of BPA was more prominent in participants with BMI less than 24 kg/m 2 than those with higher BMI. In our data, BPA concentration was higher in participants with higher BMI [0.82 (0.49 -1.47) ng/ml] than those with lower BMI [0.79 (0.44 -1.38) ng/ml], and the percentage of males was not significantly different in participants with higher BMI (40.8%) and with lower BMI (38.8%). Insulin resistance is closely associated with obesity (19) , and the association is likely a cause-andeffect relationship because human and animal studies demonstrated that weight loss significantly correlates with increasing insulin sensitivity, whereas weight gain significantly correlates with decreasing insulin sensitivity (20) . Our results suggested that the association between BPA and insulin resistance may be modulated by BMI, because the relationship between BMI and HOMA-IR was more prominent (␤ ϭ 1.51; P Ͻ 0.0001) in participants with higher BMI than in those with less BMI (␤ ϭ 0.79; P Ͻ 0.0001), the effect of higher BMI may overwhelm that of BPA on insulin resistance in participants with higher BMI.
Our study has several limitations. First, due to the cross-sectional nature, no causal relationships can be es- a For the risk of generalized overweight, we defined participants with a BMI less than 24 as 0 (n ϭ 1401) and generalized overweight as 1 (n ϭ 1372), excluding obesity participants (n ϭ 617) from the analysis. b The OR (95% CI) were adjusted for age, sex, urinary creatinine concentration, smoking, alcohol drinking, education levels, systolic blood pressure, HDL-C, LDL-C, TC, TG, hs-CRP, fasting plasma glucose, fasting serum insulin, and serum ALT and GTT. c The OR (95% CI) were further adjusted for BMI based on the adjustment indicated in footnote b.
tablished in the pathophysiological mechanism linking BPA with obesity and insulin resistance. Second, the analyses are based on morning urinary BPA concentrations, which reflect only recent exposure. Third, we did not collect data on dietary behaviors. BPA could be a marker of sugar beverages in plastic bottles, and intake of sugar beverages has been shown to be associated with obesity. In the absence of reliable dietary measures, any observational study that detects an association could have bias.
In conclusion, we reported that urinary BPA was positively and significantly associated with obesity and insulin resistance in Chinese adults aged 40 yr and older. The association between BPA exposure and the increased risk of obesity and insulin resistance seen in this population should be assessed in additional follow-up studies.
